MECLAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meclan, and what generic alternatives are available?
Meclan is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in MECLAN is meclocycline sulfosalicylate. There are twelve drug master file entries for this compound. Additional details are available on the meclocycline sulfosalicylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MECLAN?
- What are the global sales for MECLAN?
- What is Average Wholesale Price for MECLAN?
Summary for MECLAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 445 |
| DailyMed Link: | MECLAN at DailyMed |
US Patents and Regulatory Information for MECLAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | MECLAN | meclocycline sulfosalicylate | CREAM;TOPICAL | 050518-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
